Primary Cardiac Lymphoma: Italian Multicenter Experience
NCT05819528 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 43
Last updated 2026-01-05
Summary
The rationale of this study is to provide an overview on PCL (Primary Cardiac Lymphoma) in Italy, trying to shed light on unknown aspects of the disease and on unanswered questions about its management that could be helpful in clinical practice.
Conditions
- Primary Cardiac Lymphoma
Sponsors & Collaborators
-
Fondazione Italiana Linfomi - ETS
lead OTHER
Principal Investigators
-
Elisa Lucchini, MD · Trieste - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - SC Ematologia
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-02
- Primary Completion
- 2026-04-30
- Completion
- 2026-06-30
Countries
- Italy
Study Locations
More Related Trials
-
Study on Plasmablastic Lymphoma Patients
NCT06781359 ·Status: RECRUITING
-
Study of the Pronostic Impact of Immunohistochemical, Histological and Radiological Factors in Patients With Primary Central Nervous System Lymphoma.
NCT05347511 ·Status: UNKNOWN
-
A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma
NCT00944567 ·Status: COMPLETED
-
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
NCT01110733 ·Status: COMPLETED
-
Local Registry of Primary Cutaneous T-cell Lymphomas
NCT07160023 ·Status: RECRUITING
-
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
NCT05700149 ·Status: RECRUITING
-
Italian Multicenter Retrospective Observational Study on Transformed Lymphomas
NCT02927756 ·Status: UNKNOWN
-
Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.
NCT04882475 ·Status: ACTIVE_NOT_RECRUITING
-
Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)
NCT03104478 ·Status: COMPLETED
-
The Use of Biomarkers to Predict CNS Involvement in Diffuse Large B-Cell Lymphoma: a Danish Nationwide Registry Study
NCT05169203 ·Status: COMPLETED
-
Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
NCT06806488 ·Status: RECRUITING
-
Low Dose Radiotherapy in Primary Indolent Cutaneous B-cell Lymphoma
NCT07310745 ·Status: ACTIVE_NOT_RECRUITING
-
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
NCT01142674 ·Status: COMPLETED
-
TreAtments and outComes in paTients With prImary CutAneous Lymphoma
NCT05518851 ·Status: RECRUITING
-
Identification of Occupational Exposures in Acute Hematologic Malignancy
NCT03316209 ·Status: COMPLETED
-
Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients
NCT00949741 ·Status: COMPLETED
-
Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma
NCT07188077 ·Status: RECRUITING
-
Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)
NCT04300101 ·Status: RECRUITING
-
Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen
NCT01478269 ·Status: COMPLETED
-
Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular)
NCT03859544 ·Status: UNKNOWN
-
A Phase II Study of the FIL on Elderly Frail Patients With DLBCL
NCT02955823 ·Status: COMPLETED ·Phase: PHASE2
-
B-cell Chronic Lymphoid Malignancies Markers
NCT04952974 ·Status: UNKNOWN
-
Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0
NCT03265158 ·Status: UNKNOWN
-
Mechanism of Resistance to GNC-038 in Relapsed and Refractory Diffuse Large B-cell Lymphoma
NCT05189782 ·Status: UNKNOWN
-
Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab
NCT00393107 ·Status: COMPLETED ·Phase: PHASE2